calcitonin

send to a friend share this

Calcitonin receptor expression in medullary thyroid carcinoma

Medullary thyroid carcinoma (MTC) is a rare tumor representing 5–10% of thyroid cancers, with a 10-year survival rate is about 50–75%. It arises from a particular thyroid cell type: the parafollicular C-cells of the thyroid which secrete calcitonin (CT). Serum CT is a very sensitive and specific method for diagnosing MTC, however, the potential role of calcitonin receptor (CTR) expression on tumor aggressiveness and prognosis remained to be explored.

Medullary Thyroid Carcinoma Preferentially Secreting Procalcitonin


Maria João Bugalho 1,2,3, Deolinda Madureira 4, Rita Domingues 2, Teresa Pereira 5 and Luísa Cortez 6

1 Endocrinology Service, Portuguese Institute of Oncology Francisco Gentil EPE, Lisbon, Portugal.

2 Research Unit of Molecular Pathobiology, Portuguese Institute of Oncology Francisco Gentil EPE, Lisbon, Portugal.

3 University Clinic of Endocrinology, Faculty of Medical Sciences, Nova University of Lisbon, Lisbon, Portugal.